Moderna Inc (NAS:MRNA)
$ 132.135 -0.545 (-0.41%) Market Cap: 50.64 Bil Enterprise Value: 43.55 Bil PE Ratio: 0 PB Ratio: 3.95 GF Score: 68/100

Moderna Inc at Chardan Genetic Medicines Conference (Virtual) Transcript

Oct 05, 2021 / 05:00PM GMT
Release Date Price: $332.11 (+1.92%)
Yevgeniya Livshits
Chardan Capital Markets, LLC, Research Division - Senior Research Analyst

Hello, and it's now my pleasure to introduce our next fireside chat guest, Dr. Stephen Hoge, President of Moderna. Stephen, thank you again for joining us today.

Questions & Answers

Yevgeniya Livshits
Chardan Capital Markets, LLC, Research Division - Senior Research Analyst

And maybe let's start off by big picture items. So last year, when you participated in our conference, Moderna was a Phase III company, and now millions of people have received the Moderna COVID-19 vaccine. We've seen the pipeline advance, and you've announced a number of research and manufacturing initiatives. So before we talk about these topics in a bit more detail, can you comment at a high level on Moderna's trajectory and priorities going forward?

Stephen Hoge
Moderna, Inc. - President

Well, thank you, and thanks again for having me back. I enjoyed it so much last year and the year before. So this will be an exciting chance to reprise

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot